Given that cellular homeostasis is dysregulated in human cancers due to imbalances in protein phosphorylation, which results in global cellular signaling perturbations, the therapeutic targeting of phosphatases such as PP2A has emerged as an effective therapeutic strategy to reestablish cellular homeostasis [18–28]. Here, PTPA is linked to cancer.